Selectable gene marker system based on expression of...

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S006120, C435S007100, C435S455000, C435S456000

Reexamination Certificate

active

07078179

ABSTRACT:
A method is described for the rapid identification and isolation of cells based on the presence or absence of an ectopically-expressed N-acetyllactosaminide 3-α Galactosyltransferase (αGT) enzyme for the production of αGalactosyl-(1,3)Galactosyl (αGal) epitopes on the surface of αGal-negative cells. These cells which are genetically modified to express the αGT enzyme and αGal epitopes on glycosylated lipids and proteins of the cell surface are then labeled via an antibody composition which recognizes and binds the αGal epitopes on the cell surface. Cells labeled with the anti-αGal antibody can be isolated by sorting via fluorescence activated cell sorting (FACS), or by magnetic panning techniques. This method is suitable for the rapid positive or negative selection of αGal-positive cells from within a population of αGal-negative cells without the need to expose cells to antibiotics for any period of time. In addition, the specification provides a method for the production and purification of anti-αGal antibodies from chicken egg yolk.

REFERENCES:
patent: 2001/0034028 (2001-10-01), Link et al.
Bouhours J-F, Richard C, Ruvoen N, Barreau N, Naulet J, Bouhours D, Characterization of a polyclonal anti-Gala1-3Gal antibody from chicken, 1998, Glycoconjugate Journal 15:93-99.
Zurcher AW, Lang AB, Aebischer I, Miescher S, Stadler BM, IgE-producing hybridomas establihed after B-cell culture in the CD40 system, 1995, Immunology Letters 46:49-57.
Lehmann J, Huehn J, de la Rosa M, Maszyna F, Kretschmer U, Krenn V, Brunner M, Scheffold A, Hamann A, Expression of the integren aeb7 identifies unique subsets of CD25+ as well as CD25- regulatory T cells, 2002, Proc Natl Acad Sci USA 99:13031-13036.
Galili U et al., “Preparation of autologous leukemia and lymphoma vaccines expressing alpha-gal epitopes”, Journal of Hematotherapy and Stem Cell Research. U.S. Aug. 2001; 10(4):501-511 Aug. 2001.
La Temple D.C. et al., “Synthesis of Ε-Galactosyl Epitopes by Recombinant Ε1,3Galactosyltransferase for Opsonization of Human Tumor Cell Vaccines by Anti-Galactose”, Cancer Research, American Association for Cancer Research, Baltimore, Md, US, 56:3069-3074; Jul. 1996.
La Temple, Denise C. et al., “Increased immunogenicity of tumor vaccines complexed with anti-gal: Studies in knockout mice for Ε1, 3galactosyltransferase”, Cancer Research, American Association for Cancer Research, Baltimore, MD, US, 59(4):3417-3423; Jul. 1999.
Gorelik E., et al., “Alterations of cell surface carbohydrates and inhibition of metastatic property of murine melanomas by Ε1,3 galactosyltransferase gene transfection”, Cancer Research, American Association for Cancer Research, Baltimore, Md, US, 55(18):4168-4173; Sep. 1995.
Galili Uri et al., “Expression of Ε-gal epitopes on ovarian carcinoma membranes to be used as a novel autologous tumor vaccine”, Gynecologic Onocology, 90(1):100-108; Jul. 2003.
Yoshimura N. et al., “Expression of xenoantigen transformed human cancer cells to be susceptible to antibody-mediated cell killing”, Cancer Letters. Ireland 164(2):155-160; Mar. 2001.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Selectable gene marker system based on expression of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Selectable gene marker system based on expression of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selectable gene marker system based on expression of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3576435

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.